“We will not only focus on research but come up with technologies and products applicable in real clinical settings.”Park Sang-joon, vice president for research at Myongji Hospital, said this and other remarks on the hospital’s R&D strategy at the “2020 New Horizon Research Festival,” hosted by Myon
CancerRop said its newest testing device, Q-Sens® COVID-19 Detection Kit V2, has obtained regulatory approval on Monday.The molecular diagnostics developer said the new product uses the reverse-transcription polymerase chain reaction (RT-PCR) technique. The device can detect the Covid-19 virus by am
“Roche Diagnostics Korea is fully prepared for all the scenarios of the Covid-19 situation.”Johnny Tse, General Manager of Roche Diagnostics Korea, said so during a group interview with medical device-covering reporters, explaining how the diagnostics industry would respond to Covid-19.Korea’s respo
“Do you have any difficulties because of Covid-19?”“No, fortunately, I’m fine.”“Any other problems with your health?”“I've been taking hypertension drug (amlodipine) for two years, but my doctor gave me another medicine six months ago.”“Is your blood pressure controlled well?”“Yes, it is.”“Amlodipin
CancerRop, a molecular diagnostics company, said it obtained approval for a Covid-19 diagnostic kit, “Q-Sens® COVID-19 Detection Kit,” from the Ministry of Food and Drug Safety on Thursday.The authorized test kit uses a reverse transcription-polymerase chain reaction (RT-PCR) technique to detect the
Smiths Medical, a U.S. supplier of therapeutic devices for respiratory care in Korea, will widen contacts with Korean medical institutions and expand sales workforce, the head of the Korean offshoot said.Mickey Gwak, Regional Business Manager of Smiths Medical Korea, met with reporters on Friday to share his business plan. He said the company would improve the retail structure from September,
Curocell, Korea’s first developer of chimeric antigen receptor T (CAR-T) cell therapy, said Monday it attracted investment of 44 billion won ($37.1 million).Curocell plans to begin the clinical trials of CAR-T therapy, “CRC01,” within this year and speed up developing follow-up pipeline based on the successful drawing of investment. The company is about to conduct the first dome
“From now on, Korean hospitals should provide Transcatheter Aortic Valve Implantation (TAVI) procedures tailored for patients.”Professor Kim Hyo-soo of the Cardiology Department at the Seoul National University Hospital (SNUH) said so during an interview with Korea Biomedical Review on July 9. TAVI is an emerging treatment for aortic valve stenosis.TAVI is a non-surgical method of repl
Myongji Hospital has launched a brain tissue bank without any state funding to speed up research, diagnosis, and treatment of brain diseases. The brain tissue bank receives brain tissue donations from patients with various brain diseases such as dementia and Parkinson's disease, stroke, mental disorder, autism, and epilepsy and their families. With the donated tissues, the bank helps research
Celltrion ranked the first in the local brand reputation of listed pharmaceutical companies in June, followed by Samsung BioLogics and Celltrion Healthcare.The Korea Corporate Reputation Research Institute (KCRRI) analyzed over 115 million pieces of 120 listed drugmakers from May 24 to June 24 and released the result on Thursday.The institute gets brand reputation index (BRI) through divid
Local researchers said they have clinically proven how to diagnose Alzheimer’s disease early through blood testing.The research team, led by Professor Youn Young-chul of the Department of Neurology at Chung-Ang University College of Medicine, published a study titled, “Blood Amyloid-β Oligomerization as a Biomarker of Alzheimer’s Disease: A Blinded Validation Study,” in the Journal of Alzheime
Yuhan Corp. said its investigational anticancer drug Lazertinib has proved the efficacy and safety against lung cancer in the latest multiple clinical trials. At the virtual meeting of the American Society of Clinical Oncology (ASCO) on Friday, the company made three poster presentations on Lazertinib’s therapeutic effect against lung cancer, its effect on brain metastasis, and the findings on
Il-yang Pharmaceutical said it has obtained Russian approval to evaluate its leukemia drug Supect in a phase-3 trial to treat the new coronavirus. Supect is Korea’s 18th novel drug.Alpharm, a Russian drug company, will lead the phase-3 study on Supect.Earlier, Il-yang and Alpharm submitted an investigational new drug application to the Russian authorities and received the green light to go
“It is true Canon Medical Systems is a latecomer in the local medical imaging market. But the market situation will change. You will see Canon Medical taking the No. 1 position in computed tomography (CT).”Kim Young-joon, who took office as the CEO of Canon Medical Systems Korea in January, made this and other remarks at a meeting with reporters covering medical devices news on Wednesday. Kim
The regulator has suspended the sales of 31 metformin-containing diabetes drugs due to possible carcinogen risk on Tuesday, virtually kicking them out of the market.However, diabetic patients will not have to worry about their medications because physicians can prescribe many other alternatives.Still, JW Pharmaceutical and Hanall Biopharma are expected to suffer a significant drop in sales
“Now is the time to reaffirm the identity of the National Evidence-based Healthcare Collaborating Agency (NECA) and to lead changes and innovation. The agency will actively seek efforts to make the healthcare system more efficient.”Han Kwang-hyub, who recently took office as the fifth president of NECA, said so during an interview with Korea Biomedical Review.Han vowed to enhance the NECA’
The Ministry of Health and Welfare said it would reassess whether choline alfoscerate, a dementia treatment, was worth receiving the national health insurance benefit.The Health Insurance Policy Review Committee under the ministry said Friday it would review the drug’s reimbursement.The ministry cited the reasons for the reevaluation as following: the insurance claims have recently increas
Korean patients with multidrug-resistant tuberculosis (TB) will likely get faster and better treatment than now. The Korea Centers for Disease Control and Prevention (KCDC) said it has recently published the fourth edition of the TB treatment guidelines that focused on rapid diagnosis and broader use of new drugs. Along with the new instructions, the government will discuss reimbursement for n
A mobile health care application used for an obesity treatment program, jointly supported by a local public health center and a private hospital, helped people lose weight significantly, a medical report showed.Professor Shin Hyun-young at the Family Medicine Department of Myongji Hospital and her r
“Cancer” is the area where multidisciplinary treatments are being made most vigorously. Various researches and the introduction of groundbreaking technologies have raised expectations about the “complete recovery” of cancer. However, the methods to diagnose and treat cancer have also become so much diversified and guidelines, accordingly complicated. It is never easy for doctors to grasp pouring i